Fact CheckerSign in

NCT07565831Active, not recruiting

Study on the Prediction of Regional Lymph Node Metastasis in Colorectal Cancer by Spectral CT Combined With MSI

Source: ClinicalTrials.gov · Last updated 4 May 2026

Brief summary (registry, in English)

Spectral CT was used to prospectively collect medical images and clinical data related to colorectal cancer, evaluate the effect of image quality in the diagnosis of colorectal cancer, and evaluate the application value in the accurate staging of colorectal cancer, so as to provide a more accurate clinical basis for diagnosis, promote the development of individualized treatment, and ultimately improve the prognosis of patients.

Status (registry)
Active, not recruiting
Study type
Interventional
Enrollment
260 (estimated)
First submitted
27 Apr 2026
Start date
4 Aug 2025
Primary completion date
31 Dec 2026
Lead sponsor
Yunnan Cancer Hospital
NCT number
NCT07565831

What you commit to

  • Study type: Interventional
  • Planned participants: 260
  • From 4 Aug 2025 to the primary completion date, 31 Dec 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • (1) Severe cardiac, pulmonary, or renal insufficiency;(2) Allergy to iodine-based contrast agents;(3) Inability to cooperate during the CT examination;(5) Poor image quality from Quark spectral CT scans;(6) Pregnant or lactating women.

Who the study is looking for

  • (1) Undergo contrast-enhanced Quark energy spectral CT examination of the lower abdomen/pelvis within 1 week before treatment;(2) MSI status confirmed;(3) Age \>18 years;(4) Patients with suspected colorectal cancer;(5) Patients who provided informed consent.

Age in the registry: 18 years to 90 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Yunnan Cancer Hospital
Coordinator of this site? Confirm its status
KunmingChinaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.